The federal Conservatives are questioning the Liberal government about its ties with the global consulting firm McKinsey & Co. after a recent report alleged the company previously pitched a drug company on methods to boost its sales of highly addictive opioids in Canada.
The memo, titled “Identifying Growth Opportunities in Canada,” also said that McKinsey was looking to increase the motivation of Purdue Pharma’s pharmaceutical sales representatives by looking at “what opportunities exist to change incentive compensation to better align the sales force goals to company objectives.”
Conservative MP Garnett Genuis referenced the reported memo in the House of Commons on June 19 and said it shows that McKinsey and Purdue Pharma “did everything possible to increase sales and left the trail of human misery in their wake.”
“The opioid crisis was a result of corporate marketing and made some close friends of this Liberal government very rich,” Genuis said. “Those who got rich through the opioid crisis should pay for the recovery.”
McKinsey has denied the allegations in previous court filings and has said that it is “not a manufacturer or distributor of opioids” and also that there is “no meaningful connection between McKinsey and the opioid crisis in Canada.”
However, the Liberal government recently said that it plans on joining the lawsuit against McKinsey as a “class member” if it is certified as scheduled by next year.
The Epoch Times reached out to McKinsey & Co. and Purdue Pharma for comment but didn’t immediately hear back.